Cipla Ventures into Respiratory Diagnostics with iCaltech Investment

Cipla Ltd has announced an investment in iCaltech Innovations to enhance respiratory care diagnostics. They aim to develop innovative medical equipment, but financial details remain undisclosed. Cipla's Global COO, Achin Gupta, emphasized the importance of this strategic investment in bridging current gaps in respiratory diagnostic ecosystems.

Cipla Ltd revealed its intent to bolster respiratory diagnostics through a new investment in iCaltech Innovations, a company specializing in diagnostic medical equipment.

Although financial specifics were not disclosed, iCaltech's focus remains on developing new devices for respiratory care. This venture reinforces Cipla's role as leaders in lung health.

Achin Gupta, Global COO of Cipla, expressed the company's dedication to improving the respiratory diagnostic landscape and addressing existing gaps with this funding initiative.

(With inputs from agencies.)